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Background: The human ether-a-go-go-related gene (HERG) encodes the α-subunit of rapidly activating
delayed-rectiﬁer potassium channels. Mutations in this gene cause long QT syndrome type 2 (LQT2). In most
cases, mutations reduce the stability of the channel protein, which can be restored by heat shock (HS).
Methods: We identiﬁed the novel mutant A78T-HERG in a patient with LQT2. The purpose of the current
study was to characterize this mutant protein and test whether HS and heat shock factors (HSFs) could
stabilize the mutant protein. A78T-HERG and wild-type HERG (WT-HERG) were expressed in HEK293
cells and analyzed by immunoblotting, immunoprecipitation, immunoﬂuorescence, and whole-cell patch
clamping.
Results: When expressed in HEK293 cells, WT-HERG gave rise to immature and mature forms of the protein
at 135 and 155 kDa, respectively. A78T-HERG gave rise only to the immature form, which was heavily ubi-
quitinated. The proteasome inhibitor MG132 increased the expression of immature A78T-HERG and increased
both the immature and mature forms of WT-HERG. WT-HERG, but not A78T-HERG, was expressed on the
plasma membrane. In whole-cell patch clamping experiments, depolarizing pulses evoked E4031-sensitive
HERG channel currents in cells transfected with WT-HERG, but not in cells transfected with A78T-HERG. The
A78V mutant, but not A78G mutant, remained in the immature form similarly to A78T. Maturation of the
A78T-HERG protein was facilitated by HS, expression of HSF-1, or exposure to geranyl geranyl acetone.
Conclusions: A78T-HERG was characterized by protein instability and reduced expression on the plasma
membrane. The stability of the mutant was partially restored by HSF-1, indicating that HSF-1 is a target for the
treatment for LQT2 caused by the A78T mutation in HERG.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).blished by Elsevier B.V. This is an
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isatome).1. Introduction
Long QT syndrome (LQTS) is characterized by QT intervals
longer than 450 ms that lead to a torsades de pointes ventricular
tachycardia and sudden death. LQTS is attributed to mutations in
genes that encode ion channels or their regulatory proteins
responsible for the proper repolarization of cardiomyocytes [1–3],open access article under the CC BY-NC-ND license
T. Kondo et al. / Journal of Arrhythmia 32 (2016) 433–440434and is classiﬁed into 13 types based on the mutated genes. LQTS
types 1, 2, and 3 account for 90% of LQTS cases [4].
Human-ether-a-go-go-related gene (HERG) encodes the α-
subunit of rapidly-activating delayed-rectiﬁer potassium chan-
nels that generate IKr. This outward potassium current is elicited
during the plateau phase of action potentials and is required for
repolarization [4]. After being translated in the endoplasmic reti-
culum (ER), the HERG protein is transported to the Golgi apparatus
where it undergoes glycosylation [5]. This modiﬁcation transforms
the protein from the premature form into the mature form.
Eventually, HERG is transported to the plasma membrane [6]. LQTS
type 2 (LQT2) is caused by mutations in HERG [7]. In most LQT2
cases, the mutations destabilize the HERG protein and impair its
maturation and intracellular transport [8]. Sorted by the ER quality
control system, the mutant HERG protein is reverse-transported
from the ER to the cytoplasm where it is degraded by the ubi-
quitin–proteasome system, resulting in reduced HERG channel
currents and impaired repolarization of ventricular action poten-
tials [9].
It has been reported that heat shock (HS) assists both in the
folding of newly synthesized proteins and the refolding of dena-
tured proteins [10]. Molecular chaperones such as heat shock
proteins (HSPs), including Hsp90 and Hsp70, induced by HS play
an important role in the maturation of HERG [11,12]. In mammals,
the heat shock factor (HSF) family consists of 4 subtypes and
increases in response to HS to activate the transcription of mole-
cular chaperones.
In the present study, we characterized a novel mutant, A78T-
HERG, found in a patient with LQT2. The A78T-HERG protein
showed reduced stability and failed to transfer to the plasma
membrane. Its stability was partially restored by HSF-1, indicating
that HSF-1 is a target for the treatment for LQT2 caused by the
A78T mutation in HERG.2. Materials and methods
2.1. Cell culture and transfection
HEK293 cells were cultured in DMEM (Sigma, St. Louis, MO)
supplemented with 10% fetal bovine serum (JRH Biosciences, Inc.,
St. Louis, MO) and penicillin/streptomycin/geneticin at 37 °C, in a
5% CO2 atmosphere. Missense mutations were introduced into
pcDNA3/HERG-FLAG by site-directed mutagenesis. pcDNA3
expression plasmids for HSF-1, 2, and 4 were provided by A. Nakai.
Cells were transfected using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. The
total amount of cDNA was adjusted using vector cDNA.
2.2. Immunoblotting and immunoprecipitation
Cells were harvested 48 h after transfection and lysed by
sonication in lysis buffer (PBS supplemented with 1% poly-
oxyethylene octylphenyl ether, 0.5% sodium deoxycholate, 0.1%
SDS, 1.5 mM aprotinin, 21 mM leupeptine, 15 mM pepstain, and
1 mM phenylmethylsulfonylﬂuoride). After removal of insoluble
materials by centrifugation, protein concentrations were deter-
mined by the bicinchoninic acid protein assay using a commer-
cially available kit (Pierce Biotechnology, Rockford, IL). Proteins
were separated by SDS-PAGE and electrotransferred to PVDF
membranes. The membranes were blocked with 5% non-fat dry
milk in PBS containing 0.1% Tween and probed with the primary
antibody. Antibodies against the following proteins were used:
FLAG epitope (Cosmo Bio USA, Carlsbad, CA), β-actin (Nuclea
Diagnostic Laboratories, LLC/Oncogene Science, Cambridge, MA),
and green ﬂuorescent protein (GFP, Molecular Probes, ThermoFisher Scientiﬁc, Waltham, MA). The blots were developed using
an ECL system (Amersham, Biosciences, Amersham, UK). Immu-
noprecipitation was carried out at 4 °C overnight in PBS supple-
mented with 1% Triton X-100, 0.5% SDS, 0.25% sodium deox-
ycholate, 1 mM EDTA, and protease inhibitors. Immune complexes
were collected using protein G agarose (Pharmacia, Uppsala,
Sweden) and bound proteins were analyzed by SDS-PAGE followed
by immunoblotting. Band densities were quantiﬁed using NIH
image J software (Bethesda, MD) and normalized to the densities
of β-actin.
2.3. Immunoﬂuorescence
HEK293 cells on gelatin-coated coverslips were transfected
with pcDNA3/HERG-FLAG and pAcGFP-Mem constructs (Clontech
Laboratories, Inc., Mountain View, CA). Twenty-four hours after
transfection, the cells were ﬁxed in 4% paraformaldehyde/PBS and
then permeabilized with 0.5% Triton X-100. Next, the cells were
incubated for 1 h at room temperature with the primary antibody
(FLAG, 1:1000). After blocking in 3% albumin, bound antibodies
were visualized with Alexa Fluor 546-conjugated mouse second-
ary antibody (1:2000), and images were obtained using a Bio-Rad
MRC 1024 confocal microscope (Bio-Rad, Hercules, CA).
2.4. Electrophysiological recordings
HEK293 cells were transfected with pcDNA3/HERG-FLAG
(0.5 μg) and either pcDNA3/HSF-1, HSF-2 or HSF-4 (0.5 μg) toge-
ther with pEGFP (0.2 μg). The total amount of cDNA was adjusted
using vector cDNA (0.5 μg) for the dominant negative suppression
experiments. Twenty-four hours after transfection, the cells were
visualized by EGFP ﬂuorescence and HERG channel currents cor-
responding to IKr were measured at 37 °C using whole-cell patch-
clamping techniques with an Axopatch-200 ampliﬁer (Axon
Instruments, Inc., Union City, CA). The extracellular solution con-
tained (mM) NaCl 140, KCl 4, CaCl2 1.8, MgCl2 0.53, NaH2PO4 0.33,
glucose 5.5, and HEPES 5 (pH 7.4 with NaOH). The internal pipette
solution contained (mM) K-aspartate 100, KCl 20, CaCl2 1, Mg-ATP
5, EGTA 5, HEPES 5, and creatine phosphate dipotassium 5 (pH
7.2 with KOH). The membrane potential was held at 50 mV,
depolarized by 1-s test pulses (from 40 to þ40 mV in 10-mV
increments), and then repolarized back to the holding potential.
E4031, an anti-arrhythmic drug and blocker selective for HERG,
was added at 10 μM. E4031-sensitive currents were used to
characterize HERG channel currents as precisely as possible.
2.5. Statistical analysis
All data are presented as the mean7SEM. For statistical ana-
lysis, Student’s t-test and repeated measures analysis of variance
(two-way ANOVA) were used, with Po0.05 considered statisti-
cally signiﬁcant.3. Results
3.1. Characterization of the LQT2 patient
A 7-year-old boy was diagnosed with LQT2. The QT interval was
535 ms and the QT interval corrected for heart rate was 496 ms
(Fig. 1A). There were no abnormal ﬁndings on the chest X-ray ﬁlm,
ultrasonic cardiogram, or treadmill exercise test. Direct sequencing
of HERG (KCNH2) alleles identiﬁed the mutation G232A (A78T) in
one allele (Fig. 1B). A78 is in the N-terminal intracellular domain of
the HERG channels (Fig. 1C). No other mutations were detected.
220 230 240
A GAC TG C A G C C C C C CC CG G G G G
CAG CGC CGC GCT GCC GCG CAG
78
232
Q R AR A A Q
CAG CGC CGC ACT GCC GCG CAG
78
232
T
A78T
H2N
hERG
Control
Patient
Q R R A A Q
V2
Fig. 1. Characterization of the LQT2 patient. (A) Electrocardiogram of the patient with LQT2. (B) Novel HERG (KCNH2) mutation, G232A (A78T), in the patient. The patient
was heterozygous for the missense mutation. (C) Schematic representation of the HERG (KCNH2) channel, indicating the A to T substitution at position 78.
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Fig. 2. Expression of wild-type HERG (WT-HERG) and mutant (A78T-HERG). (A) Western blots showing WT-HERG (lane 1: WT) and A78T-HERG (lane 2: A78T) expressed in
HEK293 cells. Cell lysates were subjected to immunoblotting (IB) with indicated antibodies. (B) Quantiﬁcation of immature and mature HERG proteins. Bars indicate the
levels of 155 kDa mature and 135 kDa immature forms of WT-HERG and A78T-HERG (n¼4 each) normalized to the levels of β-actin. *Po0.01 vs. WT.
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Fig. 3. Ubiquitination of WT-HERG and A78T-HERG proteins. (A) Representative blots of ubiquitinated WT-HERG and A78T-HERG proteins. Cell lysates were subjected to
anti-FLAG immunoprecipitation (IP). 80% of the IP products were subjected to anti-ubiquitin immunoblotting; the other 20% were subjected to anti-FLAG and anti-HERG
antibody immunoblotting. (B) Quantiﬁcation of ubiquitinated proteins. Bar graphs indicate the levels of ubiquitinated WT-HERG or A78T-HERG proteins normalized to those
of β-actin (n¼4 each). *Po0.001 vs. WT-HERG.
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Fig. 4. Effects of proteasome inhibitor on HERG expression. (A) Representative western blots showing the levels of mature and immature WT-HERG and A78T-HERG proteins.
Cells were transfected with the WT-HERG or A78T-HERG-FLAG plasmids and cultured overnight in the absence or presence of MG132 (10 μM). (B) Quantiﬁcation of immature
and mature HERG proteins in the absence (CTRL) and presence of MG132. Band densities are expressed as the ratios to those of β-actin (n¼4 each).
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When expressed in HEK293 cells, WT-HERG-FLAG gave rise to
immature and mature proteins of 135 kDa and 155 kDa, respec-
tively. In contrast, A78T-HERG gave rise to an immature protein
only (Fig. 2A). There was a signiﬁcant reduction in the mature
protein in cells transfected with A78T-HERG compared to trans-
fection with WT-HERG (Fig. 2B). Cotransfection of the A78-HERG
and WT-HERG plasmids (0.5 μg each) reduced the mature band of
155 kDa, while transfection with the same amount of WT-HERGand vector plasmid (0.5 μg) yielded the mature band, indicating a
dominant-negative effect of A78T-HERG (Supplementary Fig. 1A).3.3. Ubiquitination of A78T-HERG proteins and effects of proteasome
inhibitor
Representative ubiquitination of the A78T-HERG and WT-HERG
proteins is shown in Fig. 3A. Ubiquitination of A78T-HERG proteins
was much more abundant than that of WT-HERG proteins.
Quantiﬁcation of ubiquitination, obtained from 4 different
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Fig. 5. Intracellular localization of HERG proteins and channel currents. (A) Immunoﬂuoresence of WT-HERG and A78T-HERG expressed in HEK293 cells. All cells were
stained with anti-FLAG and Alexa Fluor 546-conjugated secondary antibody. Shown are representative images obtained by confocal microscopy. HEK293 cells expressing
WT-HERG or A78T-HERG-FLAG (red) together with AcGFP-Mem (green). Bar, 10 μm. (B) E4031-sensitive HERG currents recorded by whole-cell patch clamp. The upper panel
shows representative original current traces recorded from HEK293 cells expressing WT-HERG or A78T-HERG-FLAG. Current–voltage relationships of peak currents are
shown in the lower panel. *Po0.001 vs. WT.
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Fig. 6. Effects of amino acid substitutions at position 78 on the expression level of
immature and mature HERG proteins. Shown are representative western blots
showing the levels of WT, A78T, A78G, and A78V-HERG expressed in HEK293 cells.
Cell lysates were subjected to immunoblotting with indicated antibodies.
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signiﬁcantly ubiquitinated compared to the WT-HERG protein.
Treatment with the proteasome inhibitor MG132 increased the
mature form of WT-HERG proteins but not that of A78T-HERG,
whereas the immature forms of both WT-HERG and A78T-HERG
were increased (Fig. 4A and B).
3.4. Cell-surface expression of A78T-HERG and its channel activity
Representative immunoﬂuorescence images of cells expressing
WT-HERG or A78T-HERG are shown in Fig. 5A. The signal from the
WT-HERG protein, but not that of the A78T-HERG protein, co-
localized with that from AcGFP-Mem. Representative original
traces of HERG channel currents in HEK293 cells expressing WT-
HERG or A78T-HERG are shown in Fig. 5B. The E4031-sensitive
outward currents and tail currents were largely time-dependent
and observed in cells expressing WT-HERG, whereas there were
only small E4031-sensitive outward currents with no detectable
tail current in cells expressing A78T-HERG. The current–voltage
relationship of HERG channel currents in cells expressing WT-
HERG or A78T-HERG (Fig. 5B, lower panel; n¼10) shows that therewas a signiﬁcant reduction in peak outward HERG currents in cells
expressing A78T-HERG. As shown in Supplementary Fig. 1B, cells
transfected with both the WT-HERG and A78T-HERG plasmids
gave rise to reduced E4031-sensitive currents, indicating a domi-
nant negative effect of the mutant.
3.5. Effects of amino acid substitutions on HERG expression
The type and position of a mutation in a gene inﬂuences pro-
tein structure and stability [13]. To clarify whether the key factor
for instability of the A78T mutant is the change in molecular size
or hydrophobicity (or both) at position 78, we investigated the
effect of substituting the amino acid alanine (A) at position 78
with valine (V), which is similar in molecular radius to a threonine
residue (larger than an alanine residue), but is a non-polar amino
acid similarly to alanine. For A78T, A78V failed to give rise to the
mature form of HERG. Next, in order to evaluate the importance of
the methyl group, we constructed another mutant, A78G-HERG, in
which the alanine at position 78 was substituted with glycine (G),
which has no methyl group and is smaller than alanine. The
mature form of the HERG protein was detected when A78G-HERG
was expressed, suggesting a tolerance for deletion of the methyl
group, i.e., a decrease in size and hydrophobicity (Fig. 6).
3.6. Effects of HS, HSF-1, and a HSF-1 inducer on the maturation of
A78T-HERG protein
Heat shock increases HSF levels and facilitates the maturation
of WT-HERG proteins [11]. HS at 42 °C for 1 h increased the
expression of the mature 155 kDa protein of A78T-HERG (Fig. 7A),
which was conﬁrmed in four different experiments (B). HSP
expression is regulated by HSF-1, 2, and 4. HSF-1 increased the
mature form of A78T-HERG, whereas neither HSF-2 nor 4 inﬂu-
enced the maturation of A78T-HERG (Fig. 8A, left panel), which
was conﬁrmed in three different experiments (A, right panel).
Geranyl geranyl acetone (GGA) at 200 nM, which is an inducer of
HSF-1, also facilitated the maturation of A78T-HERG.
Representative original current traces recorded from cells
expressing A78T-HERG after treatment with HS are shown in
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Fig. 7. Effect of heat shock (HS) on A78T-HERG expression. (A) Western blots showing the levels of immature and mature A78T-HERG proteins with and without HS
treatment. (B) Quantiﬁcation of immature and mature HERG proteins to determine the effect of HS (n¼4 each). *Po0.01 vs. A78T without HS.
A78T
A78T+HS
A78T+HSF-1
1000ms
1nA
A78T
N=4
HSF1
N=4
HSF2
N=4
HSF4
N=4
GGA
N=4
hE
R
G
no
rm
al
iz
ed
 im
ag
e 
de
ns
ity
155kDa mature protein
*
*
HSF1A78T HSF4HSF2 GGA
135-
155-FLAG
HSF2
-actin
IB:
HSF1
GFP
HSF4
80-
60-
50-
E4031-sensitivity currents
0
0.1
0.2
0.3
0.4
0.5
0.6
-40 -20 0 20 40 60
0
5
10
15
20
25
30
Test potential (mV)
E
40
31
-s
en
si
tiv
ity
 c
ur
re
nt
s 
(p
A /
pF
)
*
*
*
* * *
*
*
**
**
*
*
HS
A78T
HSF1
*
β
Fig. 8. Effects of heat shock factor (HSF) family protein expression and GGA on the maturation of A78T-HERG proteins. (A) Western blots showing the levels of A78T-HERG
proteins. HEK293 cells were transfected with pcDNA3/A78T-HERG-FLAG and pEGFP, together with pcDNA3/HSF-1, HSF-2, or HSF-4. The HSF-1 activator GGA at 200 nM was
added to the culture medium at 36 h after transfection and the cells were further cultured for 12 h. Right panel shows quantiﬁcation of the 155 kDa mature protein (n¼4
each). *Po0.001 vs. control (A78T). (B) Representative HERG current traces (left) and current–voltage relationships (right). Currents were recorded 24 h after HS treatment at
42 °C for 1 h (middle) or 24 h after transfection with pcDNA3/A78T-HERG and HSF-1 (bottom). Current–voltage relationships of E4031-sensitive peak currents showed
signiﬁcant increases in A78T-HERG currents by HS or co-expression with HSF-1 (n¼10 each). *Po0.001 vs. control (A78T).
T. Kondo et al. / Journal of Arrhythmia 32 (2016) 433–440438Fig. 8B (left panel). A signiﬁcant increase in the E4031-sensitive
mutant channel current was observed in cells treated with HS. The
current–voltage relationships of A78T-HERG currents in trans-
fected cells with or without HS treatment, obtained from ten
experiments, are also shown in Fig. 8B (right panel). The E4031-
sensitive peak outward A78T-HERG currents signiﬁcantly
increased in cells treated with HS. This effect of HS was mimicked
by co-expression with HSF-1.4. Discussion
The novel HERG mutation A78T, found in a patient with LQT2,
was located at the N-terminus of HERG proteins. The A78T-HERG
protein failed to mature and was expressed as a highly ubiquiti-
nated 135-kDa immature protein. Since ubiquitination of the
protein to be degraded by the proteasome is known to occur in the
core-glycosylated immature form at the ER [11,12], this ﬁnding
T. Kondo et al. / Journal of Arrhythmia 32 (2016) 433–440 439indicates the impaired stability of A78T-HERG proteins to be
degraded via the ubiquitin proteasome system. Protein maturation
is facilitated by the accumulation of immature proteins (mass
effect) as well as by posttranslational modiﬁcations including
glycosylation. In the present study, MG132 increased the expres-
sion of the 135-kDa immature form of A78T-HERG, but not that of
the 155-kDa mature form, suggesting that the accumulation of
immature A78T-HERG did not facilitate its maturation. We pre-
viously demonstrated that MG132 increased the expression of the
mature form of Kv1.5, a voltage-gated potassium channel, indi-
cating that accumulated immature wild-type Kv1.5 protein could
be converted to its mature form as a result of the mass effect [14].
Since a substantial portion of Kv1.5 is degraded via the ubiquitin–
proteasome system, proteasomal inhibition results in the accu-
mulation of a large amount of immature Kv1.5, facilitating its
maturation as a mass effect. In contrast, during the synthesis of
WT-HERG, most of the core-glycosylated immature protein is
converted to the fully-glycosylated mature form [6]. Thus, accu-
mulation of the immature form of HERG protein in a setting of
proteasomal inhibition is lower than that of Kv1.5. The failure of
MG132 to increase the expression of mature A78T-HERG suggests
that accumulation of immature A78T-HERG is not sufﬁcient to
exert a mass effect, while accumulation of immature A78T-HERG
may not increase its mature form because of severe dysfunction of
its maturation process.
Since the type and position of a mutation in the gene inﬂuence
protein structure and stability [13], the A78T mutation may
destabilize the HERG protein because of an alteration in the
molecular radius or hydrophobicity of the amino acid at position
78. A78G-HERG yielded the mature protein, whereas A78V-HERG,
similarly to A78T-HERG, did not. The former ﬁnding excludes the
possibility that deletion of the methyl group by substitution for
alanine destabilizes the A78T-HERG protein. The latter ﬁnding
suggests that the larger molecular radius but not hydrophilicity of
the threonine residue destabilizes A78T-HERG.
Heat shock facilitates the folding of various proteins as medi-
ated by the HSP family and can stabilize mutant proteins. HS has
been reported to facilitate maturation of WT-HERG as well as
mutant HERG by activating the HSF family [15]. HSF-1, 2, and
4 were reported to be expressed in humans. HSF-1 is a master
regulator of Hsp70 and Hsp90. HSF-2 plays roles in the develop-
ment of the brain and reproductive organs and acts as a major
regulator of the proteostasis capacity against febrile-range thermal
stress to prevent the accumulation of misfolded proteins [16]. HSF-
4, which possesses transcriptional repressor properties in vivo,
inhibits basal transcription of Hsp27 and Hsp90 in cultured cells
[17]. In the present study, we found that HSF-1, but not HSF- 2 or 4,
increased the expression of mature A78T-HERG protein. These
results suggest that HSF-1 stabilizes A78T-HERG protein, promotes
its transport to the plasma membrane, and increases the mem-
brane current IKr.
The ubiquitin proteasome system in cardiomyocytes, including
HL-1 cells and neonatal rat cardiomyocytes, involves three activ-
ities: chymotrypsin-like, trypsin-like, and caspase-like activities.
The degradation of several ion channel proteins showed similar
time courses between cardiomyocytes and HEK293 cells, indicat-
ing no difference in ubiquitin–proteasome system activities in
these cells. Thus, mutant HERG proteins such as A78T-HERG may
be degraded through the ubiquitin–proteasome system in cardi-
omyocytes as well [18]. Accordingly, the clinical implications of
our results are as follows. To date, many studies have shown that
maturation of mutant HERG proteins can be improved by low
temperature or HS and by application of E-4031 or a gastro-
prokinetic agent such as cisapride [19–21]. GGA is a non-toxic
acyclic isoprenoid compound with a retinoid skeleton that
increases Hsp70 expression by activating HSF-1 [22]. In thepresent study, GGA at the clinical concentration of 200 nM facili-
tated maturation of the A78T-HERG protein, suggesting that GGA
is of therapeutic value for patients with LQT2 caused by the A78T
mutation in HERG.5. Conclusions
The A78T-HERG protein showed reduced stability and failed to
transfer to the plasma membrane. Its stability was partially
restored by HSF-1, indicating that HSF-1 is a potential target for
the treatment for LQT2 caused by the A78T mutation in HERG.Conﬂict of interest
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